117 related articles for article (PubMed ID: 37149423)
1. Contribution of HLA-G and FOXP3 genes and proteins in the severity of cervical intraepithelial neoplasia during HPV infection.
da Silva NCH; Sonon P; Medeiros FS; da Silva MC; Dos Santos Gomes FO; Peixoto CA; Crispim JCO; Paiva LA; Rygaard MCV; Menezes MLB; Welkovic S; Donadi EA; Lucena-Silva N
Hum Immunol; 2023 Aug; 84(8):408-417. PubMed ID: 37149423
[TBL] [Abstract][Full Text] [Related]
2. Case-control study of HLA-G promoter methylation status, HPV infection and cervical neoplasia in Curitiba, Brazil: a pilot analysis.
Gillio-Tos A; Bicalho Mda G; Fiano V; Grasso C; Tarallo V; De Marco L; Trevisan M; Xavier M; Slowik R; Carvalho NS; Maestri CA; Lacerda HM; Zugna D; Richiardi L; Merletti F
BMC Cancer; 2012 Dec; 12():618. PubMed ID: 23265140
[TBL] [Abstract][Full Text] [Related]
3. FOXP3 immunoregulatory gene variants are independent predictors of human papillomavirus infection and cervical cancer precursor lesions.
Cezar-Dos-Santos F; Ferreira RS; Okuyama NCM; Trugilo KP; Sena MM; Pereira ÉR; Pereira APL; Watanabe MAE; de Oliveira KB
J Cancer Res Clin Oncol; 2019 Aug; 145(8):2013-2025. PubMed ID: 31177386
[TBL] [Abstract][Full Text] [Related]
4. Human leukocyte antigen G polymorphism is associated with an increased risk of invasive cancer of the uterine cervix.
Ferguson R; Ramanakumar AV; Koushik A; Coutlée F; Franco E; Roger M;
Int J Cancer; 2012 Aug; 131(3):E312-9. PubMed ID: 22095460
[TBL] [Abstract][Full Text] [Related]
5. Understanding HLA-G driven journey from HPV infection to cancer cervix: Adding missing pieces to the jigsaw puzzle.
Aggarwal R; Sharma M; Mangat N; Suri V; Bhatia T; Kumar P; Minz R
J Reprod Immunol; 2020 Nov; 142():103205. PubMed ID: 33099242
[TBL] [Abstract][Full Text] [Related]
6. HLA DOA1 and DOB1 loci in Honduran women with cervical dysplasia and invasive cervical carcinoma and their relationship to human papillomavirus infection.
Ferrera A; Olivo A; Alaez C; Melchers WJ; Gorodezky C
Hum Biol; 1999 Jun; 71(3):367-79. PubMed ID: 10380373
[TBL] [Abstract][Full Text] [Related]
7. Implication of HLA-G 3' untranslated region polymorphisms in human papillomavirus infection.
Bortolotti D; Gentili V; Rotola A; Di Luca D; Rizzo R
Tissue Antigens; 2014 Feb; 83(2):113-8. PubMed ID: 24397524
[TBL] [Abstract][Full Text] [Related]
8. Identification of human leukocyte antigen in precancerous and cancerous cervical lesions from Ecuadorian women.
Mora MJ; de Los Ángeles Bayas-Rea R; Mejía L; Cruz C; Guerra S; Calle P; Sandoval DM; Galarza JM; Zapata-Mena S
Infect Genet Evol; 2022 Nov; 105():105365. PubMed ID: 36108945
[TBL] [Abstract][Full Text] [Related]
9. Association between HLA-DRB1 polymorphism, high-risk HPV infection and cervical neoplasia in southern Chinese.
Chan PK; Cheung TH; Lin CK; Siu SS; Yim SF; Lo KW; Cheung JL; Tam AO; Tang JW
J Med Virol; 2007 Jul; 79(7):970-6. PubMed ID: 17516530
[TBL] [Abstract][Full Text] [Related]
10. HLA-G polymorphisms in women with squamous intraepithelial lesions harboring human papillomavirus.
Simões RT; Gonçalves MA; Castelli EC; Júnior CM; Bettini JS; Discorde ML; Duarte G; Quintana SM; Simões AL; Moreau P; Carosella ED; Soares EG; Donadi EA
Mod Pathol; 2009 Aug; 22(8):1075-82. PubMed ID: 19407850
[TBL] [Abstract][Full Text] [Related]
11. HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants.
Bontkes HJ; van Duin M; de Gruijl TD; Duggan-Keen MF; Walboomers JM; Stukart MJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ; Stevens FR; Dyer PA; Sinnott P; Stern PL
Int J Cancer; 1998 Oct; 78(2):166-71. PubMed ID: 9754647
[TBL] [Abstract][Full Text] [Related]
12. Human Leukocyte Antigen-G (HLA-G) Expression in Precancerous and Cancerous Cervical Lesions: Association with Human Papilloma Virus Infection and Host Immune Response.
Fahim NM; Shehata IH; Taha SE; Fahmy RA; Elsayed MS
Egypt J Immunol; 2018 Jan; 25(1):125-134. PubMed ID: 30243004
[TBL] [Abstract][Full Text] [Related]
13. Langerhans' cell count and HLA class II profile in cervical intraepithelial neoplasia in the presence or absence of HIV infection.
Gonçalves MA; Soares EG; Fernandes AP; Fonseca BA; Bettini JS; Simões RT; Donadi EA
Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):221-7. PubMed ID: 15140519
[TBL] [Abstract][Full Text] [Related]
14. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome.
de Gruijl TD; Bontkes HJ; Walboomers JM; Coursaget P; Stukart MJ; Dupuy C; Kueter E; Verheijen RH; Helmerhorst TJ; Duggan-Keen MF; Stern PL; Meijer CJ; Scheper RJ
J Gen Virol; 1999 Feb; 80 ( Pt 2)():399-408. PubMed ID: 10073700
[TBL] [Abstract][Full Text] [Related]
15. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
Hudelist G; Manavi M; Pischinger KI; Watkins-Riedel T; Singer CF; Kubista E; Czerwenka KF
Gynecol Oncol; 2004 Mar; 92(3):873-80. PubMed ID: 14984955
[TBL] [Abstract][Full Text] [Related]
16. High-risk cervical epithelial neoplasia grade 1 treated by loop electrosurgical excision: follow-up and value of HPV testing.
Alonso I; Torné A; Puig-Tintoré LM; Esteve R; Quinto L; Garcia S; Campo E; Pahisa J; Ordi J
Am J Obstet Gynecol; 2007 Oct; 197(4):359.e1-6. PubMed ID: 17714678
[TBL] [Abstract][Full Text] [Related]
17. Risk association between human leukocyte antigen-A allele and high-risk human papillomavirus infection for cervical neoplasia in Chinese women.
Chan DP; Cheung TH; Tam AO; Cheung JL; Yim SF; Lo KW; Siu NS; Zhou DX; Chan PK
J Infect Dis; 2005 Nov; 192(10):1749-56. PubMed ID: 16235173
[TBL] [Abstract][Full Text] [Related]
18. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
Hildesheim A; Schiffman M; Scott DR; Marti D; Kissner T; Sherman ME; Glass AG; Manos MM; Lorincz AT; Kurman RJ; Buckland J; Rush BB; Carrington M
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1035-41. PubMed ID: 9829713
[TBL] [Abstract][Full Text] [Related]
19. Human leukocyte antigen-G (HLA-G) expression in cervical lesions: association with cancer progression, HPV 16/18 infection, and host immune response.
Dong DD; Yang H; Li K; Xu G; Song LH; Fan XL; Jiang XL; Yie SM
Reprod Sci; 2010 Aug; 17(8):718-23. PubMed ID: 20445010
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of type-specific human papillomavirus prevalence in Iranian women with normal cytology, precancerous cervical lesions and invasive cervical cancer: Implications for screening and vaccination.
Jalilvand S; Shoja Z; Nourijelyani K; Tohidi HR; Hamkar R
J Med Virol; 2015 Feb; 87(2):287-95. PubMed ID: 25156655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
